What does this research mean for the field?

Question

Accepted Answer

Posttransplant cyclophosphamide-based GVHD prophylaxis is safe and effective in adult recipients of HLA-mismatched unrelated donor allogeneic hematopoietic cell transplantation requiring reduced intensity or non-myeloablative conditioning, demonstrating generalizability across multiple centers. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Phase II Study of Posttransplant Cyclophosphamide‐Based Graft‐Versus‐Host Disease Prophylaxis After HLA ‐Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort

Discussion

Member takes

Overview

Key Points

Cite This Study